Moreover, the vaccine significantly stimulated mucosal immunity, as evidenced by the presence of specific IgA antibodies in tracheal and intestinal lavage fluid, which are essential for defending against respiratory and gastrointestinal infections. This evidence concerns the gene CD79A and digestive system infectious disorder.